Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
delayed orgasm.
Popular Articles

States Undergo A Variety Of Health Care Policy Developments
Connecticut: The Associated Press/Hartford Courant reports, "Gov. M. Jodi Rell has vetoed two health insurance bills he said were "well-intentioned" but "would cost the state billions of dollars before any economic recovery is complete." Unions and health care advocates had pressured the Republican governor to sign the measures. "[O]ne of the billsò€¦ opens the state"s health insurance plan to municipalities, small businesses and nonprofit agencies. The second bill creates a new public authority to develop a plan to extend coverage to the state"s uninsured." It"s not yet clear if Democrats, who have a veto-proof majority in the General Assembly, will try to override Rell"s action (7/8).
generic viagra
Close Relationship With Caregivers Slows Alzheimer's
A group of Utah State University researchers and colleagues at Johns Hopkins University, Duke University and Boston University have demonstrated that the rate of clinical progression of dementia may be slowed by a close relationship with one"s caregiver. The findings will be published in the September 2009 issue of "The Journals of Gerontology Series B: Psychological Sciences and Social Sciences" by Oxford Journals
News of the day
Physicians Support New Immunizations, Urge Children To Get Vaccinations
New rules require more vaccinations before a child can start kindergarten or seventh grade this fall. The physicians of the Texas Medical Association (TMA) are urging parents to get their child"s shots now before school starts.
Cardiovascular

New Clinical Study On Type 2 Diabetes Begins Enrollment At New York Hospital Queens

Diabetes affects nearly 24 million people in the United States. The most widespread form is type 2 diabetes, accounting for about 90 to 95 percent of all diagnosed cases of diabetes, according to the American Diabetes Association (ADA). The research team at New York Hospital Queens is offering the community a chance to participate in a new type 2 diabetes study. The study, called TINSAL-T2D (Targeting Inflammation using Salsalate in Type 2 Diabetes), looks at the safety and effectiveness of an investigational medication (similar to aspirin) in the treatment of type 2 diabetes. The study medication has been approved by the U.S. Food and Drug Administration to treat arthritis, but it has not yet been approved for diabetes. To be eligible for this study, participants must have type 2 diabetes, be between 18 and 75 years old, and be on a stable dose of oral anti-diabetic medication and the diabetes is still not well controlled. The study includes 12 visits to the Lang Research Center over approximately one year. Qualified participants will receive a physical exam and laboratory tests at no cost. Participants will be compensated for their time and effort. Nationally lauded endocrinologist, Daniel Lorber, M.D., associate director, Eugene and Theresa Lang Research Center for Research and Education at New York Hospital Queens, is the principal investigator of the clinical trial. Last month, Dr. Lorber received the ADA"s "Outstanding Physician Clinician Award" for his contributions to the ongoing fight against diabetes. A clinical trial is a scientific study that evaluates the safety and effectiveness of medical treatments, drugs or devices. These studies are required by the U.S. Food and Drug Administration for manufacturers to earn approval for new products and new uses for existing products. New York Hospital Queens is a member of the NewYork-Presbyterian Healthcare System and is an affiliate of the Weill Medical College of Cornell University. American Diabetes Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009